Xuantai Pharmaceuticals (688247.SH): The approval number for the sustained-release hydrochloride acetophenone tablet has been obtained from INVIMA in Colombia.

The Zhitong Finance and Economics APP learned that Xuantai Pharmaceuticals (688247.SH) issued an announcement. Recently, the company received a notification from the National Food and Drug Surveillance Agency of Colombia (referred to as "INVIMA" in Colombia) that its generic drug application for sustained-release tablets of Venlafaxine Hydrochloride has been officially approved. The main ingredient of Venlafaxine Hydrochloride sustained-release tablets is Venlafaxine Hydrochloride, which belongs to the class of amino-ketone antidepressant drugs. The approved indications for this application are the treatment of severe depression and the prevention of seasonal affective disorder.